Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shortages Mostly FDA’s Fault, House Oversight Committee Concludes

This article was originally published in The Pink Sheet Daily

Executive Summary

Report says aggressive enforcement in recent years has forced capacity offline, which led to shortages.

You may also be interested in...



Surge In Applications Triggers User Fee Inflation

With full NDA and BLA submissions to FDA now growing faster than INDs and supplements, user fees are increasing more rapidly as well.

Track & Trace – And Delay: Pharmacies Get Enforcement Discretion From FDA

FDA's grace period for transaction information sharing means that distribution channels will operate more smoothly, but also could result in more missed deadlines down the road.

FDA Policy Power Challenged In House Questions On Untitled Letters

Oversight and Investigations Subcommittee Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours. The Energy and Commerce Committee examines whether FDA use of untitled letters is “fair, effective and efficient in gaining compliance,” he says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS074287

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel